While the combination of ATRA/ATO with chemotherapy may represent a viable initial approach for TBL1XR1-RARB-positive APL, the observed high relapse rate underscores the potential necessity of hematopoietic stem cell transplantation as a curative intervention for this variant form of APL. The gene discussed is RARB; the disease is acute promyelocytic leukemia.